suHCO (Systemic Sustainability Transition Solution for Health Care Organisations) is a European project funded under the Horizon Europe programme (Grant Agreement No. 101226802) and implemented through a Pre-Commercial Procurement (PCP) scheme. The project aims to support health and care organisations in their transition towards more sustainable and environmentally responsible models by fostering the development of innovative digital solutions. Through the PCP process, suHCO will procure research and development services for the creation of an AI-enabled digital platform capable of helping healthcare organisations assess their sustainability performance, identify improvement opportunities, plan and implement actions, monitor progress, and support evidence-based decision-making. The future solution is expected to integrate sustainability knowledge, regulatory requirements, standards, best practices and relevant data sources, providing users with practical guidance tailored to their organisational context. It should also support sustainable procurement processes, impact assessment, reporting activities and organisational change management. The project is driven by a Buyers Group composed of healthcare organisations from Spain, Italy and Wales. The solutions developed during the PCP will be progressively designed, prototyped and validated in real healthcare environments to ensure their relevance, usability and scalability. By bringing together healthcare providers, technology developers and sustainability experts, suHCO seeks to stimulate innovation and contribute to the sustainability objectives of European health systems.
Anuncio de licitación (2026-06-30) Objeto Alcance de la contratación
Título: Pre-commercial Procurement of an innovative Systemic Sustainability Transition Solution for Health Care Organisations (suHCO)
Breve descripción:
suHCO (Systemic Sustainability Transition Solution for Health Care Organisations) is a European project funded under the Horizon Europe programme (Grant Agreement No. 101226802) and implemented through a Pre-Commercial Procurement (PCP) scheme.
The project aims to support health and care organisations in their transition towards more sustainable and environmentally responsible models by fostering the development of innovative digital solutions.
Through the PCP process, suHCO will procure research and development services for the creation of an AI-enabled digital platform capable of helping healthcare organisations assess their sustainability performance, identify improvement opportunities, plan and implement actions, monitor progress, and support evidence-based decision-making.
The future solution is expected to integrate sustainability knowledge, regulatory requirements, standards, best practices and relevant data sources, providing users with practical guidance tailored to their organisational context. It should also support sustainable procurement processes, impact assessment, reporting activities and organisational change management.
The project is driven by a Buyers Group composed of healthcare organisations from Spain, Italy and Wales. The solutions developed during the PCP will be progressively designed, prototyped and validated in real healthcare environments to ensure their relevance, usability and scalability.
By bringing together healthcare providers, technology developers and sustainability experts, suHCO seeks to stimulate innovation and contribute to the sustainability objectives of European health systems.
suHCO (Systemic Sustainability Transition Solution for Health Care Organisations) is a European project funded under the Horizon Europe programme (Grant Agreement No. 101226802) and implemented through a Pre-Commercial Procurement (PCP) scheme.
The project aims to support health and care organisations in their transition towards more sustainable and environmentally responsible models by fostering the development of innovative digital solutions.
Through the PCP process, suHCO will procure research and development services for the creation of an AI-enabled digital platform capable of helping healthcare organisations assess their sustainability performance, identify improvement opportunities, plan and implement actions, monitor progress, and support evidence-based decision-making.
The future solution is expected to integrate sustainability knowledge, regulatory requirements, standards, best practices and relevant data sources, providing users with practical guidance tailored to their organisational context. It should also support sustainable procurement processes, impact assessment, reporting activities and organisational change management.
The project is driven by a Buyers Group composed of healthcare organisations from Spain, Italy and Wales. The solutions developed during the PCP will be progressively designed, prototyped and validated in real healthcare environments to ensure their relevance, usability and scalability.
By bringing together healthcare providers, technology developers and sustainability experts, suHCO seeks to stimulate innovation and contribute to the sustainability objectives of European health systems.
Tipo de contrato: Servicios
Productos/servicios: Servicios de investigación y desarrollo experimental📦
Valor estimado sin IVA: 2 260 980 EUR 💰
Descripción
Esta contratación también es adecuada para las pequeñas y medianas empresas (pymes) ✅
Descripción de la contratación:
Procurement will take the form of pre-commercial procurement (PCP), where R&D service contracts will be awarded in parallel to different R&D providers in a phased approach. This will allow alternative, competing solutions to be compared. Each selected operator will receive a framework contract covering three R&D phases. The three phases are: Solution design, prototype development, original development and validation and testing of a limited volume of the first products or services. After each phase, interim evaluations are conducted to select the best of the competing solutions. The contractors with the best value for money will be offered a specific contract for the next phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed.
Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). This testing may also serve as a first customer test reference for the contractors.
The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement.
This procurement is funded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No. 101226802- suHCO (https://suhco.eu/). The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.
Procurement will take the form of pre-commercial procurement (PCP), where R&D service contracts will be awarded in parallel to different R&D providers in a phased approach. This will allow alternative, competing solutions to be compared. Each selected operator will receive a framework contract covering three R&D phases. The three phases are: Solution design, prototype development, original development and validation and testing of a limited volume of the first products or services. After each phase, interim evaluations are conducted to select the best of the competing solutions. The contractors with the best value for money will be offered a specific contract for the next phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed.
Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). This testing may also serve as a first customer test reference for the contractors.
The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement.
This procurement is funded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No. 101226802- suHCO (https://suhco.eu/). The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.
Emplazamiento principal o lugar de actuación:
Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy).
Duración
Fecha de inicio: 2026-12-01 📅
Fecha final: 2028-11-30 📅
Criterios de adjudicación
Criterio de calidad (nombre): Available in the tender documents
Título
Número de identificación del lote: LOT-0001 Descripción
Emplazamiento principal o lugar de actuación:
Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy)
Alcance de la contratación
Productos/servicios adicionales:
Descripción
Código postal: 08022
Localidad: Barcelona
Camarthen
Treviso
País:
España 🇪🇸
Reino Unido 🇬🇧
Italia 🇮🇹
Procedimiento Tipo de procedimiento
Procedimiento abierto ✅
Base jurídica: Directiva 2014/24/UE
Información administrativa
Plazo de recepción de las ofertas o solicitudes de participación: 2026-10-09 14:00:00 📅
Lenguas en las que pueden presentarse las ofertas o solicitudes de participación: inglés 🗣️
Plazo mínimo durante el cual el licitador debe mantener la oferta: 6 meses Información sobre un acuerdo marco o un sistema dinámico de adquisición
Acuerdo marco con varios operadores ✅ Condiciones de la licitación
Facturación electrónica: Obligatoria
Se utilizará el pago electrónico ✅
Información jurídica, económica, financiera y técnica Procedimiento
Derecho transfronterizo aplicable: Spanish Law 9/2017
Procurement will take the form of pre-commercial procurement (PCP), where R&D service contracts will be awarded in parallel to different R&D providers in a phased approach. This will allow alternative, competing solutions to be compared. Each selected operator will receive a framework contract covering three R&D phases. The three phases are: Solution design, prototype development, original development and validation and testing of a limited volume of the first products or services. After each phase, interim evaluations are conducted to select the best of the competing solutions. The contractors with the best value for money will be offered a specific contract for the next phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed.
Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). This testing may also serve as a first customer test reference for the contractors.
The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement.
The research and development (R&D) services will be carried out primarily within the European Union and/or in countries associated with the Horizon Europe Programme. At least 50% of the total value of the R&D activities shall take place within the EU or associated countries. Contractors must ensure that none of the contracted services is performed in countries nor by entities that are subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU)23 (sanctions). They must also ensure that none of the goods procured or used for the procurement were developed, produced or supplied in countries or by entities that are subject to such restrictive measures.
This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs.
Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation.
This procurement is funded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No. 101226802- suHCO (https://suhco.eu/). *The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.*
Procurement will take the form of pre-commercial procurement (PCP), where R&D service contracts will be awarded in parallel to different R&D providers in a phased approach. This will allow alternative, competing solutions to be compared. Each selected operator will receive a framework contract covering three R&D phases. The three phases are: Solution design, prototype development, original development and validation and testing of a limited volume of the first products or services. After each phase, interim evaluations are conducted to select the best of the competing solutions. The contractors with the best value for money will be offered a specific contract for the next phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed.
Testing is expected to take place in Catalonia (Spain), West Wales (UK), Treviso (Italy). This testing may also serve as a first customer test reference for the contractors.
The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement.
The research and development (R&D) services will be carried out primarily within the European Union and/or in countries associated with the Horizon Europe Programme. At least 50% of the total value of the R&D activities shall take place within the EU or associated countries. Contractors must ensure that none of the contracted services is performed in countries nor by entities that are subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU)23 (sanctions). They must also ensure that none of the goods procured or used for the procurement were developed, produced or supplied in countries or by entities that are subject to such restrictive measures.
This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs.
Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation.
This procurement is funded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No. 101226802- suHCO (https://suhco.eu/). *The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.*
Organismo responsable de los procedimientos de mediación
Nombre: HDUHB Hywel Dda University Health Board
Número de registro nacional: NA
Dirección postal: Corporate Offices, Ystwyth Building, Hafan Derwen, St Davids Park, Jobswell Road
Código postal: SA31 3BB
Ciudad postal: Camarthen
País: Reino Unido 🇬🇧
Correo electrónico: suppliers@suhco.eu📧
URL: https://hduhb.nhs.wales/🌏 Órgano de revisión Igual que: Nombre y dirección Servicio del que puede obtenerse información sobre el procedimiento de recurso
Nombre: Istituto per Servizi di Ricovero e Assistenza agli Anziani (ISRAA)
Número de registro nacional: IT00737700260
Dirección postal: Borgo Giuseppe Mazzini, 48
Código postal: 31100
Ciudad postal: Treviso
Región: Treviso
🏙️
País: Italia 🇮🇹 Información sobre flujos de trabajo electrónicos
Se aceptará la facturación electrónica
Fuente: OJS 2026/S 125-454632 (2026-06-30)
Anuncio de licitación (2026-07-02) Objeto Alcance de la contratación
Valor estimado sin IVA: 2 260 980 EUR 💰
Cambios Otra información adicional
Principal motivo de la modificación: Información actualizada
Información sobre modificaciones
Versión del anuncio anterior que debe modificarse: 454632-2026
Fuente: OJS 2026/S 126-457507 (2026-07-02)